Biotech Interest Expense from 2010 to 2025
| BIOG Stock | 1,225 35.00 2.78% |
Interest Expense | First Reported 2003-09-30 | Previous Quarter 260 K | Current Value 520 K | Quarterly Volatility 101.5 K |
Check Biotech Growth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotech Growth's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 2.1 M or Other Operating Expenses of 3.1 M, as well as many indicators such as . Biotech financial statements analysis is a perfect complement when working with Biotech Growth Valuation or Volatility modules.
Biotech | Interest Expense |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biotech Stock Analysis
When running Biotech Growth's price analysis, check to measure Biotech Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Growth is operating at the current time. Most of Biotech Growth's value examination focuses on studying past and present price action to predict the probability of Biotech Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Growth's price. Additionally, you may evaluate how the addition of Biotech Growth to your portfolios can decrease your overall portfolio volatility.